EMA issues revised version of biosimilars quality guideline

posted 04/07/2014

On 26 June 2014, the European Medicines Agency (EMA) published the new version of its biosimilars quality guideline, which will revise the agency’s 2005 over...

more
32 organizations agree biosimilars should have... Biosimilars/General | Posted 04/07/2014
EMA approves biosimilar insulin Biosimilars/News | Posted 04/07/2014
Abbott to buy Russian generics firm Pharma News | Posted 04/07/2014
Patent term restoration provisions in CETA Generics/Research | Posted 04/07/2014
Biosimilar etanercept demonstrates equivalent e... Biosimilars/Research | Posted 04/07/2014
Companies required to update information on drugs Policies & Legislation | Posted 04/07/2014
Teva settles patent litigation over ProAir HFA Generics/News | Posted 04/07/2014
Massachusetts governor signs biosimilars substi... Policies & Legislation | Posted 27/06/2014
ECCO position statement on biosimilars Biosimilars/General | Posted 27/06/2014
Influence of CETA on generics Generics/Research | Posted 27/06/2014
EMA changes transparency plans to increase acce... Policies & Legislation | Posted 27/06/2014
Biosimilar infliximab comparable to Remicade Biosimilars/Research | Posted 27/06/2014
Court rules Canadian drug regulators cannot con... Policies & Legislation | Posted 27/06/2014
Can the pursuit of biosimilar interchangeabilit... Biosimilars/Research | Posted 20/06/2014
Views on biosimilars at Amgen and Actavis Pharma News | Posted 20/06/2014
Darbopoetin alfa ‘similar biologic’ launched in... Biosimilars/News | Posted 20/06/2014
EMA criticized for change in data transparency... Policies & Legislation | Posted 20/06/2014
Biosimilars of etanercept Biosimilars/General | Posted 20/06/2014
Factors influencing use of generic asthma drugs... Generics/Research | Posted 20/06/2014
Actavis settles Nuvigil patent litigation, chal... Generics/News | Posted 20/06/2014
WHO calls for better science-based regulations... Policies & Legislation | Posted 13/06/2014
Biosimilars of epoetin alfa Biosimilars/General | Posted 13/06/2014
Promoting generics prescribing in the UK Generics/Research | Posted 13/06/2014
The global biologicals market Reports | Posted 13/06/2014
European regulators give green light to Ranbaxy... Generics/General | Posted 13/06/2014
Oncobiologics and IPCA create biosimilars alliance Biosimilars/News | Posted 13/06/2014
First generic celecoxib approved by FDA Generics/News | Posted 13/06/2014
BioProduction 2014 Conferences | Posted 13/06/2014
Impact of price cuts on spending on hyperlipida... Generics/Research | Posted 06/06/2014
Top 8 blockbuster biologicals 2013 Biosimilars/General | Posted 06/06/2014
Europe–Japan cooperation on generics and biosim... Policies & Legislation | Posted 06/06/2014
Biosimilars developer Coherus raises US$55 mill... Biosimilars/News | Posted 06/06/2014
Sun Pharma’s Gujarat site under FDA import alert Generics/News | Posted 06/06/2014
Generic atypical antipsychotic drugs in Belgium Generics/Research | Posted 02/06/2014
Biosimilars of bevacizumab Biosimilars/General | Posted 02/06/2014
FDA’s faster approval of generics to benefit In... Generics/General | Posted 02/06/2014
ABPI issues updated position paper on biosimilars Biosimilars/General | Posted 02/06/2014
Pfizer to start phase III biosimilar trastuzuma... Biosimilars/News | Posted 02/06/2014
Novartis settles Gleevec lawsuit with Sun Pharma Generics/News | Posted 02/06/2014
Impact of delisting ARBs in Denmark Generics/Research | Posted 23/05/2014
more

Generics News Research General

more

Biosimilars News Research General

more